SEARLE PARTNERS WITH BEXIMCO FOR THE SUPPLY OF REMDESIVIR INJECTION TO COMBAT COVID-19

- May 25, 2020 SEARLE PARTNERS WITH BEXIMCO FOR  THE SUPPLY OF REMDESIVIR INJECTION  TO COMBAT COVID-19

In May 2020, Searle partnered with Beximco-Bangladesh for the ample supply of Bemsivir I.V. – Remdesivir Injection. Beximco is the USFDA approved first leading company in the world that developed and introduced generic Remdesivir Injection to treat hospitalized patients with severe COVID-19. Searle proudly supplied this FDA approved low price generic Remdesivir to critical patients on a cost basis. This initiative saves hundreds of lives and recovers thousands of patients.

Written by nozwpau0m1